No. 25-1126

Eli Lilly and Company v. United States, et al., ex. rel., Ronald J. Streck

Lower Court: Seventh Circuit
Docketed: 2026-03-27
Status: Pending
Type: Paid
Experienced Counsel
Tags: false-claims-act medicaid-fraud qui-tam-relator scienter separation-of-powers treble-damages
Latest Conference: N/A
Question Presented (from Petition)

1. Whether the False Claims Act's qui tam provisions are unconstitutional.

2. Whether a legal interpretation can be deemed so "objectively unreasonable" as to constitute "highly probative" evidence of scienter under the False Claims Act when it was widely held throughout the industry, no government actor rejected it, and four federal judges expressly found it reasonable.

Question Presented (AI Summary)

Whether the False Claims Act's qui tam provisions violate the separation of powers doctrine, and whether a legal interpretation can constitute evidence of scienter when it was widely held throughout the industry and found reasonable by multiple federal judges

Docket Entries

2026-03-23
Petition for a writ of certiorari filed. (Response due April 27, 2026)
2026-03-21
Petition for a writ of certiorari filed. (Response due April 27, 2026)
2026-02-09
Application (25A901) granted by Justice Barrett extending the time to file until March 21, 2026.
2026-02-04
Application (25A901) to extend the time to file a petition for a writ of certiorari from February 19, 2026 to March 21, 2026, submitted to Justice Barrett.

Attorneys

Eli Lilly and Company
Erin E. MurphyClement & Murphy, PLLC, Petitioner
Ronald J. Streck, et al.
D. John SauerSolicitor General, Respondent